Page last updated: 2024-10-29

isradipine and Diabetic Angiopathies

isradipine has been researched along with Diabetic Angiopathies in 3 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rendell, MS1
Shehan, MA1
Kahler, K1
Bailey, KL1
Eckermann, AJ1
Byington, RP1
Furberg, CD1
Craven, TE1
Pahor, M1
Sowers, JR1
Mason, RP1
Mason, PE1

Reviews

1 review available for isradipine and Diabetic Angiopathies

ArticleYear
Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
    Diabetes care, 1999, Volume: 22, Issue:7

    Topics: Calcium Channel Blockers; Cardiovascular Diseases; Diabetic Angiopathies; Humans; Hypertension; Isra

1999

Trials

2 trials available for isradipine and Diabetic Angiopathies

ArticleYear
Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
    Angiology, 1997, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers

1997
Isradipine in prediabetic hypertensive subjects.
    Diabetes care, 1998, Volume: 21, Issue:12

    Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Dis

1998